Protherics Plc - Report of Foreign Issuer (6-K)
August 11 2008 - 7:46AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
08 August, 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into
English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act
of 1934.
Yes
No
X
If “Yes” is marked, indicate below the
file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
.
The Registrant is furnishing a copy of its
announcements as reported to the Company Announcements Office of the London Stock
Exchange.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PROTHERICS PLC
|
|
|
|
|
|
|
|
|
|
Date: 08 August, 2008
|
|
By:
|
|
/s/ Rolf Soderstrom
|
|
|
|
|
|
Rolf Soderstrom
|
|
|
|
|
|
Finance Director
|
Block Listing Six Monthly Return
6% U
nsecured
C
onvertible
Loan N
otes
Lon
don, UK; Brentwood, TN, US:
8 August
2008
-
Protherics PLC ("Protherics" or the "Company"), the
international biopharmaceutical company focused on critical care an
d cancer,
in accordance with Listing Rule 3.5.6, notifies the following
details in respect of
a
block listing for
the Company's
6% Unsecured Convertible Loan Notes:
|
|
|
|
|
Block Listing in respect of
6%
Unsecured
Convertible
Loan Notes
|
|
|
|
|
|
|
Balance of unallotted securities
under scheme from previous return
:
|
8,430,060 Ordinary Shares (Loan Notes to the value
of £2,107,515)
|
The amount by which the block scheme has been
increased since the date of the last return:
|
|
Number of
securities
issued/allotted under scheme during
period:
|
292,388
Ordinary Shares (Loan
Notes to the value of £
73,097
)
|
Balance under scheme not yet issued/allotted at end
of period
|
8,137,672
Ordinary Shares (Loan N
otes to the value of £
2,034,418
)
|
Number and
class
of
securities
originally listed and the date of
admission
|
17,092,476 Ordinary Shares (Loan Notes to the
v
alue of £4,273,119
) admitted on 8 February 2005
|
Total number of
securities
in issue at the end of the period
|
342,159,034
Ordinary Shares
|
F
or f
urther
i
nformation
please contact
:
|
|
|
Nick Staples
,
Director of Corporate
Affairs
|
|
Julie Vickers, Company Secretary
|
|
|
|
|
Financial Dynamics
- press enquiries
|
|
London:
Ben Atwell, Lara Mott
|
|
New York
:
John Capodanno
|
|
Or visi
t
www.protherics.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
